Paediatrics Search
Paediatrics Paediatrics
bronchiolitis
BRONCHIOLITIS
Bronchiolitis is a clinical diagnosis preceding upper respiratory illness and/or rhinorrhea.
Signs of respiratory illness which may include wheezing, retractions, oxygen desaturation, color change, nasal flaring.
There is also presence of apnea especially in premature or low birthweight infants, signs of dehydration and exposure to persons with viral upper respiratory infections.
Symptoms are usually worst on the 3rd-5th day of illness and then improve gradually.

Bronchiolitis Patient Education

Patient Education

  • Educate parents on the basic pathophysiology and expected clinical course of bronchiolitis
  • Educate parents on proper suctioning and airway maintenance techniques
    • Other respiratory care therapies eg chest physiotherapy, cool mist therapy and aerosol therapy are generally not helpful and therefore are not recommended
    • Deep and improper suctioning has been associated with longer hospital stay
  • Provide information on signs of progressing disease which would necessitate calling health care providers:
    • Increase in respiratory rate (RR) and accessory muscle use for respiration
    • Worsening general appearance
    • Inability to maintain an acceptable hydration status
  • Propping up the patient at an angle of 10-30° may ease breathing difficulty
  • Inform parents that symptoms of bronchiolitis (ie cough) usually resolves within 3 weeks from diagnosis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
What is the chief complaint of patients hospitalized with a first myocardial infarction?
6 days ago
Chest pain appears to be the principal complaint of patients hospitalized with a first myocardial infarction (MI), particularly among those in the youngest age group, a study has found.
High dose comparable to lower doses of ACE inhibitors for heart failure
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
How to control asthma well: Experts’ perspectives
Pearl Toh, 6 days ago
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
PCI tied to death, MI, stroke in patients with LMCA, LV dysfunction
Yesterday
Percutaneous coronary intervention (PCI), compared with coronary artery bypass grafting (CABG), in the revascularization of left main coronary artery (LMCA) disease may lead to death, myocardial infarction (MI), or stroke in patients with moderate or severe left ventricular (LV) dysfunction, reveals a study.